SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001178913-22-001706
Filing Date
2022-04-29
Accepted
2022-04-29 17:10:25
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A zk2227705.htm   iXBRL 10-K/A 416260
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 5921
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 6122
  Complete submission text file 0001178913-22-001706.txt   868091

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE entx-20211231.xsd EX-101.SCH 4407
5 XBRL CALCULATION FILE entx-20211231_cal.xml EX-101.CAL 33766
6 XBRL DEFINITION FILE entx-20211231_def.xml EX-101.DEF 151599
7 XBRL LABEL FILE entx-20211231_lab.xml EX-101.LAB 24343
8 XBRL PRESENTATION FILE entx-20211231_pre.xml EX-101.PRE 19559
10 EXTRACTED XBRL INSTANCE DOCUMENT zk2227705_htm.xml XML 9086
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38556 | Film No.: 22877341
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences